Open AccessWhat Should Be Chronic: The Animal, the Model, or Both?
Author(s) -
Rubio Gustavo A.,
Elliot Sharon J.,
Glassberg Marilyn K.
Publication year - 2016
Publication title -
stem cells translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.781
H-Index - 71
eISSN - 2157-6580
pISSN - 2157-6564
DOI - 10.5966/sctm.2015-0325
Subject(s) - mesenchymal stem cell , bleomycin , idiopathic pulmonary fibrosis , pulmonary fibrosis , medicine , fibrosis , stromal cell , animal model , translational research , stem cell , translational medicine , lung , immunology , pathology , bioinformatics , biology , genetics , chemotherapy
The systematic review of mesenchymal stromal cell (MSC) therapy in pulmonary fibrosis by Srour and Thébaud published in a recent issue of S tem C ells T ranslational M edicine is critically reviewed; Rubio et al. suggest that bleomycin‐induced lung injury in aged mice studied over time is a more clinically applicable model for human idiopathic pulmonary fibrosis.